Blog

What Is Retatrutide? Triple Agonist Peptide for Fat Loss and Diabetes

In a world already transformed by GLP-1 agonists like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro), a new compound is pushing the boundaries of what’s possible in fat loss and metabolic correction: Retatrutide. Developed by Eli Lilly, Retatrutide is a triple agonist — meaning it simultaneously activates GLP-1, GIP, and glucagon receptors. This multi-receptor strategy sets it […]

Blog

Tesofensine for Fat Loss: Mechanism, Benefits, Dosage, and Body Recomp Stacks

Tesofensine isn’t your typical fat burner. Originally developed to treat neurodegenerative conditions like Parkinson’s and Alzheimer’s, this compound showed a surprising “side effect” during early clinical trials: rapid and sustained weight loss. Unlike caffeine-based thermogenics or GLP-1 agonists, Tesofensine works through a completely different mechanism. It alters brain chemistry by inhibiting the reuptake of dopamine, […]